NL194067C - Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. - Google Patents

Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. Download PDF

Info

Publication number
NL194067C
NL194067C NL8701743A NL8701743A NL194067C NL 194067 C NL194067 C NL 194067C NL 8701743 A NL8701743 A NL 8701743A NL 8701743 A NL8701743 A NL 8701743A NL 194067 C NL194067 C NL 194067C
Authority
NL
Netherlands
Prior art keywords
aspartame
citric acid
nac
acetylcysteine
effervescent
Prior art date
Application number
NL8701743A
Other languages
English (en)
Dutch (nl)
Other versions
NL8701743A (nl
NL194067B (nl
Original Assignee
Inpharzam Internat S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4245841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL194067(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inpharzam Internat S A filed Critical Inpharzam Internat S A
Publication of NL8701743A publication Critical patent/NL8701743A/nl
Publication of NL194067B publication Critical patent/NL194067B/xx
Application granted granted Critical
Publication of NL194067C publication Critical patent/NL194067C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8701743A 1986-07-24 1987-07-23 Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. NL194067C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2975/86A CH667590A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
CH297586 1986-07-24

Publications (3)

Publication Number Publication Date
NL8701743A NL8701743A (nl) 1988-02-16
NL194067B NL194067B (nl) 2001-02-01
NL194067C true NL194067C (nl) 2001-06-05

Family

ID=4245841

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701743A NL194067C (nl) 1986-07-24 1987-07-23 Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.

Country Status (8)

Country Link
BE (1) BE1000355A3 (enrdf_load_stackoverflow)
CH (1) CH667590A5 (enrdf_load_stackoverflow)
DE (1) DE3723735A1 (enrdf_load_stackoverflow)
FR (1) FR2601876B1 (enrdf_load_stackoverflow)
GB (1) GB2192790B (enrdf_load_stackoverflow)
IT (1) IT1222104B (enrdf_load_stackoverflow)
NL (1) NL194067C (enrdf_load_stackoverflow)
SE (1) SE500494C2 (enrdf_load_stackoverflow)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
ES2084971T3 (es) * 1991-01-26 1996-05-16 Senju Pharma Co Un agente para desintegrar calculos biliares.
DE4103360A1 (de) * 1991-02-05 1992-08-06 Koehler Peter Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
DE19509856C2 (de) * 1995-03-17 1997-09-11 Schwabe Willmar Gmbh & Co Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen
WO2000018392A1 (en) * 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
EP1115842A4 (en) 1998-09-25 2002-08-21 Glycox Corp Ltd Fructosamine oxidase assay: methods and materials
EP2500018B1 (en) 2002-03-08 2017-07-19 PhilERA New Zealand Limited Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
MXPA05002883A (es) 2002-08-20 2005-10-05 Protemix Corp Ltd Formas de dosis y terapias relacionadas.
CA2577634C (en) 2004-07-19 2015-07-07 Protemix Corporation Limited Synthesis of triethylenetetramines
TR200900882A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102233139B (zh) * 2010-04-21 2012-09-05 重庆健能医药开发有限公司 一种乙酰半胱氨酸泡腾片及其制备方法和应用
EP2571499A1 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Pharmaceutical composition comprising n- acetylcysteine and a xanthine
CN101947211A (zh) * 2010-08-28 2011-01-19 浙江金华康恩贝生物制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法
TR201104738A2 (tr) * 2011-05-16 2012-12-21 Bi̇lgi̇ç Mahmut N-Asetilsistein içeren farmasötik kombinasyon.
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine
EP2905020A1 (en) * 2014-02-05 2015-08-12 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations comprising ibuprofen and N-acetylcystein
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
ZA723683B (en) * 1971-07-12 1973-06-27 Hoffmann La Roche Improved effervescent preparations
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Also Published As

Publication number Publication date
SE8702940D0 (sv) 1987-07-23
NL8701743A (nl) 1988-02-16
NL194067B (nl) 2001-02-01
GB2192790A (en) 1988-01-27
SE8702940L (sv) 1988-01-25
GB8717582D0 (en) 1987-09-03
FR2601876B1 (fr) 1989-10-13
BE1000355A3 (fr) 1988-11-08
FR2601876A1 (fr) 1988-01-29
IT8721411A0 (it) 1987-07-23
SE500494C2 (sv) 1994-07-04
DE3723735C2 (enrdf_load_stackoverflow) 1992-05-21
GB2192790B (en) 1990-01-31
DE3723735A1 (de) 1988-02-04
IT1222104B (it) 1990-08-31
CH667590A5 (it) 1988-10-31

Similar Documents

Publication Publication Date Title
NL194067C (nl) Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.
NL194154C (nl) Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat.
US5073376A (en) Preparations containing l-carnitine
RU2184570C2 (ru) Препараты для орального введения
US6149938A (en) Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
CA2303770C (en) Multilayered soft capsule for eliminating foul breath and process for producing the same
FI85648B (fi) Foerfarande foer framstaellning av en bornerande, snabbt loeslig komposition som innehaoller ett terapeutiskt medel.
CA1291044C (en) Spray dried acetaminophen
CA1329130C (en) Ranitidine
US20060039973A1 (en) Effervescent composition including water soluble dietary fiber
EA000046B1 (ru) Оральная композиция, содержащая s(+)-ибупрофен, и способ ее получения
HUP0103016A2 (hu) Nemkívánatos íz gátlása orális készítményekben
IE61952B1 (en) Spray dried acetaminophen
JPH02164820A (ja) イブプロフェン風味マスク法
HU206265B (en) Process for producing pharmaceutical compositions comprising morphine
WO2000051570A1 (fr) Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
AU711853B2 (en) Oral formulations of S(+)-etodolac
KR20040075075A (ko) 제형
RU2324474C2 (ru) Жевательная таблетка, содержащая лизин
EP1310233A2 (en) Process for making compositions comprising titanium dioxide
CA1297035C (en) Chewable, non-gritty calcium citrate tablet
WO2001097803A1 (en) Pharmaceutical preparations comprising racecadotril (acetorphan)
LT4530B (lt) Farmacinės kompozicijos diklofenako pagrindu
EP0769294B1 (en) Taste-masked aqueous solutions comprising ibuprofen and menthol
FR2786395A1 (fr) Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: INPHARZAM S.A.

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070723